COMPASS Pathways plc SEC filings CMPS

COMPASS Pathways plc has 344 filings in SEC EDGAR's recent list, going back to Jul 2, 2020. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

COMPASS Pathways plc SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 28, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 7, 2026 —
4 Insider transaction Aug 5, 2026 Aug 3, 2026
S-3ASR Automatic shelf registration Aug 5, 2026 —
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 7, 2026 Jul 7, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
3 Initial insider ownership May 29, 2026 May 27, 2026
8-K Current report
Shareholder vote results
May 28, 2026 May 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 15, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 15, 2026 May 27, 2026
4 Insider transaction Mar 27, 2026 Mar 26, 2026
4 Insider transaction Mar 27, 2026 Mar 26, 2026
4 Insider transaction Mar 27, 2026 Mar 26, 2026
S-8 Employee stock plan registration Mar 24, 2026 —
S-8 Employee stock plan registration Mar 24, 2026 —
10-K Annual report Mar 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 24, 2026 Mar 24, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
4 Insider transaction Mar 3, 2026 Mar 2, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Feb 19, 2026 Feb 18, 2026
424B5 Prospectus supplement Feb 19, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 17, 2026 —
424B5 Prospectus supplement Feb 17, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Feb 17, 2026 Feb 17, 2026
4 Insider transaction Feb 3, 2026 Feb 2, 2026
8-K Current report
Material agreement, New debt
Jan 7, 2026 Jan 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
4 Insider transaction Oct 31, 2025 Oct 29, 2025
3 Initial insider ownership Oct 31, 2025 Oct 29, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 29, 2025 —
8-K Current report
Officer or director change
Oct 29, 2025 Oct 26, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 4, 2025 Aug 1, 2025
8-K Current report
Results of operations
Jul 31, 2025 Jul 31, 2025
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
4 Insider transaction Jul 30, 2025 Jul 29, 2025
3 Initial insider ownership Jul 30, 2025 Jul 29, 2025
8-K Current report
Officer or director change
Jul 29, 2025 Jul 28, 2025
8-K Current report
Other events
Jun 23, 2025 Jun 23, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
424B5 Prospectus supplement May 8, 2025 —
EFFECT Filing May 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 7, 2025 —
CORRESP Letter to the SEC May 5, 2025 —
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 28, 2025 Apr 28, 2025
PRE 14A Preliminary proxy statement Apr 16, 2025 Apr 16, 2025
8-K Current report
Auditor change, Officer or director change
Apr 16, 2025 Apr 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 15, 2025 —
4 Insider transaction Mar 13, 2025 Mar 11, 2025
4 Insider transaction Mar 13, 2025 Mar 11, 2025
4 Insider transaction Mar 13, 2025 Mar 11, 2025
UPLOAD Letter from the SEC Mar 6, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 5, 2025 —
4 Insider transaction Mar 4, 2025 Mar 3, 2025
S-8 Employee stock plan registration Feb 27, 2025 —
S-3 Shelf registration Feb 27, 2025 —
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 6, 2025 —
4 Insider transaction Feb 5, 2025 Feb 3, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 17, 2025 —
424B5 Prospectus supplement Jan 10, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jan 10, 2025 Jan 9, 2025
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Results of operations
Oct 31, 2024 Oct 31, 2024
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
4 Insider transaction Oct 25, 2024 Oct 24, 2024
4 Insider transaction Oct 25, 2024 Oct 24, 2024
424B5 Prospectus supplement Oct 18, 2024 —
EFFECT Filing Oct 17, 2024 —
CORRESP Letter to the SEC Oct 15, 2024 —
UPLOAD Letter from the SEC Oct 11, 2024 —
S-3 Shelf registration Oct 7, 2024 —
4 Insider transaction Sep 27, 2024 Sep 26, 2024
SC 13D/A Amended ownership over 5% (active) Sep 27, 2024 —
4 Insider transaction Sep 4, 2024 Sep 3, 2024
3 Initial insider ownership Sep 4, 2024 Sep 3, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
8-K Current report
Results of operations, Officer or director change
Aug 1, 2024 Jul 30, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
4 Insider transaction May 22, 2024 May 20, 2024
4 Insider transaction May 22, 2024 May 20, 2024
F-6EF Filing May 15, 2024 —
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
8-K Current report
Shareholder vote results, Other events
May 9, 2024 May 9, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Other events
May 8, 2024 May 8, 2024
4 Insider transaction May 6, 2024 May 2, 2024
4 Insider transaction May 6, 2024 May 2, 2024
4 Insider transaction May 3, 2024 May 1, 2024
4 Insider transaction Apr 18, 2024 Apr 16, 2024
4 Insider transaction Apr 18, 2024 Apr 16, 2024
SC 13G Ownership over 5% (passive) Apr 11, 2024 —
ARS Annual report to shareholders Apr 8, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 8, 2024 Apr 8, 2024
4 Insider transaction Apr 2, 2024 Apr 1, 2024
4 Insider transaction Apr 2, 2024 Apr 1, 2024
4 Insider transaction Apr 1, 2024 Mar 28, 2024
4 Insider transaction Apr 1, 2024 Mar 28, 2024
PRE 14A Preliminary proxy statement Mar 28, 2024 Mar 28, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 28, 2024 Mar 27, 2024
4 Insider transaction Mar 14, 2024 Mar 12, 2024
4 Insider transaction Mar 14, 2024 Mar 12, 2024
144 Notice of proposed sale Mar 13, 2024 —
144 Notice of proposed sale Mar 13, 2024 —
4 Insider transaction Mar 5, 2024 Mar 1, 2024
3 Initial insider ownership Mar 5, 2024 Mar 1, 2024
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 27, 2024 Feb 23, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Jan 23, 2024 Jan 19, 2024
4 Insider transaction Jan 23, 2024 Jan 19, 2024
S-8 Employee stock plan registration Jan 5, 2024 —
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
SC 13G Ownership over 5% (passive) Jan 2, 2024 —
SC 13G Ownership over 5% (passive) Jan 2, 2024 —
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
144 Notice of proposed sale Dec 13, 2023 —
144 Notice of proposed sale Dec 13, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 7, 2023 Dec 5, 2023
4 Insider transaction Nov 2, 2023 Nov 1, 2023
4 Insider transaction Nov 2, 2023 Nov 1, 2023
4 Insider transaction Nov 2, 2023 Nov 1, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
3 Initial insider ownership Oct 27, 2023 Oct 26, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 26, 2023 Oct 24, 2023
4 Insider transaction Sep 20, 2023 Sep 18, 2023
3 Initial insider ownership Sep 20, 2023 Sep 18, 2023
424B3 Prospectus Sep 19, 2023 —
EFFECT Filing Sep 18, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 18, 2023 Sep 13, 2023
CORRESP Letter to the SEC Sep 14, 2023 —
UPLOAD Letter from the SEC Sep 14, 2023 —
S-3 Shelf registration Sep 8, 2023 —
SC 13G Ownership over 5% (passive) Aug 28, 2023 —
SC 13G Ownership over 5% (passive) Aug 25, 2023 —
4/A Form 4/a Aug 24, 2023 Aug 1, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 16, 2023 Aug 16, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CMPS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Chesire, United Kingdom
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1816590
Former names
Compass Rx Ltd. (until Aug 10, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.